National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 39052 [2021-15647]
Download as PDF
<![CDATA[
39052
Federal Register / Vol. 86, No. 139 / Friday, July 23, 2021 / Notices
Department of Health and Human
Services.
ACTION: Notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel. The meetings
will be closed to the public in
accordance with the provisions set forth
in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Institutional
Training Program (T32) Review SEP.
Date: October 25, 2021.
Time: 09:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959 Bethesda, MD
20892, (301) 451–3398, hayesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: July 19, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–15647 Filed 7–22–21; 8:45 am]
BILLING CODE 4140–01–P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC)
Substance Abuse and Mental
Health Services Administration,
AGENCY:
VerDate Sep<11>2014
16:49 Jul 22, 2021
Jkt 253001
The Secretary of Health and
Human Services announces a meeting of
the Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC). The ISMICC is open to the
public and can be accessed via
telephone or webcast only, and not in
person. Agenda with call-in information
will be posted on SAMHSA’s website
prior to the meeting at: https://
www.samhsa.gov/about-us/advisorycouncils/meetings. The meeting will
include information on federal efforts
related to serious mental illness (SMI)
and serious emotional disturbance
(SED).
DATES: August 27, 2021, 1:00 p.m.–5:00
p.m. (EDT)/Open.
ADDRESSES: The meeting will be held
virtually and can be accessed via Zoom.
FOR FURTHER INFORMATION CONTACT:
Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers
Lane, 14E53C, Rockville, MD 20857;
telephone: 240–276–1279; email:
pamela.foote@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
I. Background and Authority
The ISMICC was established on
March 15, 2017, in accordance with
section 6031 of the 21st Century Cures
Act, and the Federal Advisory
Committee Act, 5 U.S.C. App., as
amended, to report to the Secretary,
Congress, and any other relevant federal
department or agency on advances in
SMI and SED, research related to the
prevention of, diagnosis of, intervention
in, and treatment and recovery of SMIs,
SEDs, and advances in access to services
and supports for adults with SMI or
children with SED. In addition, the
ISMICC will evaluate the effect federal
programs related to SMI and SED have
on public health, including public
health outcomes such as: (A) Rates of
suicide, suicide attempts, incidence and
prevalence of SMIs, SEDs, and
substance use disorders, overdose,
overdose deaths, emergency
hospitalizations, emergency room
boarding, preventable emergency room
visits, interaction with the criminal
justice system, homelessness, and
unemployment; (B) increased rates of
employment and enrollment in
educational and vocational programs;
(C) quality of mental and substance use
disorders treatment services; or (D) any
other criteria determined by the
Secretary. Finally, the ISMICC will
make specific recommendations for
actions that agencies can take to better
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
coordinate the administration of mental
health services for adults with SMI or
children with SED. Not later than one
(1) year after the date of enactment of
the 21st Century Cures Act, and five (5)
years after such date of enactment, the
ISMICC shall submit a report to
Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal
members listed below or their
designees, and non-federal public
members.
Federal Membership: Members
include, The Secretary of Health and
Human Services; The Assistant
Secretary for Mental Health and
Substance Use; The Attorney General;
The Secretary of the Department of
Veterans Affairs; The Secretary of the
Department of Defense; The Secretary of
the Department of Housing and Urban
Development; The Secretary of the
Department of Education; The Secretary
of the Department of Labor; The
Administrator of the Centers for
Medicare and Medicaid Services; and
The Commissioner of the Social
Security Administration.
Non-Federal Membership: Members
include, 15 non-federal public members
appointed by the Secretary, representing
psychologists, psychiatrists, social
workers, peer support specialists, and
other providers, patients, family of
patients, law enforcement, the judiciary,
and leading research, advocacy, or
service organizations.
The ISMICC is required to meet at
least twice per year.
To attend virtually, submit written or
brief oral comments, or request special
accommodation for persons with
disabilities, contact Pamela Foote.
Individuals can also register on-line at:
https://snacregister.samhsa.gov/
MeetingList.aspx.
The public comment section will be
scheduled at the conclusion of the
meeting. Individuals interested in
submitting a comment, must notify
Pamela Foote on or before August 20,
2021 via email to: Pamela.Foote@
samhsa.hhs.gov.
Up to three minutes will be allotted
for each approved public comment as
time permits. Written comments
received in advance of the meeting will
be considered for inclusion in the
official record of the meeting.
Substantive meeting information and
a roster of Committee members is
available at the Committee’s website:
https://www.samhsa.gov/about-us/
advisory-councils/meetings.
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 86, Number 139 (Friday, July 23, 2021)]
[Notices]
[Page 39052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15647]
[[Page 39052]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel. The
meetings will be closed to the public in accordance with the provisions
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Institutional Training
Program (T32) Review SEP.
Date: October 25, 2021.
Time: 09:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 959
Bethesda, MD 20892, (301) 451-3398, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: July 19, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15647 Filed 7-22-21; 8:45 am]
BILLING CODE 4140-01-P
